Prof. Dr. Rainer Fietkau

Lehrstuhl für Strahlentherapie

Pradictive Character of Immunophenotyping in peripheral Blood in Patients treated with PD-1 Immunocheckpoint Inhibitors with and without Radiotherapy (Prospective Phase IV Study ST-ICI) (2018) Hecht M, Donaubauer AJ, Harrer A, Rutzner S, Becker I, Lettmaier S, Haderlein M, et al. Conference contribution Predictors of long-term survival following radical treatment of oligometastatic NSCLC with cerebral metastases (2018) Hirschmann E, Zoske H, Weissmann T, Lettmaier S, Filimonova I, Fietkau R, Putz F Conference contribution Paragangliomas of the head and neck-local control and functional outcomes following stereotactic radiotherapy (2018) Weissmann T, Semrau S, Fietkau R, Putz F Conference contribution LOW DOSE RADIATION HAS A POSITIVE IMPACT ON BONE METABOLISM IN AN EXPERIMENTAL MODEL OF INFLAMMATORY ARTHRITIS (2018) Deloch L, Rückert M, Hueber A, Herrmann M, Fietkau R, Frey B, Gaipl U Conference contribution QOL After APBI (Multicatheter Brachytherapy) Versus WBI: 5-Year Results, Phase 3 GEC-ESTRO Trial (2018) Schaefer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, et al. Conference contribution Multicenter quality assurance evaluation of MR-guided deep hyperthermia systems (2018) Curto S, Mulder T, Aklan B, Mils O, Schmidt M, Lamprecht U, Peller M, et al. Conference contribution NAR score as surrogate for disease-free survival in the CAO/ARO/AIO-04 phase 3 rectal cancer trial (2018) Fokas E, Fietkau R, Hartmann A, Hohenberger W, Grützmann R, Ghadimi M, Liersch T, et al. Conference contribution Reliability of determining the resectability of locally progressed pancreatic ductal adenocarcinomas - results from the CONKO-007 multicenter randomized controlled trial (EudraCT:2009-014476-21) (2018) Wittel UA, Golcher H, Gruetzmann R, Bechstein WO, Belyaev O, Uhl W, Ghadimi M, et al. Conference contribution Low-dose irradiation has an impact on bone metabolism as well as on local and systemic immune cell-mediated inflammation (2018) Deloch L, Rückert M, Seeling M, Nimmerjahn F, Fietkau R, Frey B, Gaipl U Conference contribution Radio(chemo)therapy does differently impact on PD-L1 and PD-L2 expression in human melanoma cell lines (2018) Derer A, Riegel D, Frey B, Fietkau R, Gaipl U Conference contribution